Accuracy of B-scan ultrasonography in acute fundus obscuring vitreous hemorrhage using a standardized scanning protocol and a dedicated ophthalmic ultrasonographer.

PURPOSE: To assess the accuracy of B-scan ultrasound (U/S) in diagnosing cases of acute fundus obscuring vitreous hemorrhage (FOVH) using a standardized scan protocol and dedicated ophthalmic ultrasonographer. METHODS: Consecutive patients presenting with acute FOVH of unknown cause, between January 2013 and December 2014, were prospectively recruited. Patients underwent a scan performed by a dedicated ultrasonographer, utilizing a systematic scan sequence and using an ocular specific U/S device. The U/S findings were compared to the findings during vitrectomy or after spontaneous hemorrhage clearance. RESULTS: Fifty-eight eyes (58 patients) were included. An underlying rhegmatogenous retinal detachment (RRD) and retinal tears without RRD were reported in nine and 14 patients, respectively. Nineteen of these patients underwent vitrectomy, and the other four underwent laser retinopexy or cryopexy alone. An additional six patients with suspected but uncertain retinal tears underwent vitrectomy, during which tears were confirmed in three, two had retinal vessel avulsions, and one had retinal new vessels. There was "complete" agreement between the B-scan findings and clinical findings in 78% of patients, "partial" agreement in 19%, and agreement was not tested in 3%. When the agreement was "partial", the disagreements did not affect patient management. The sensitivity was 100% for the detection of RRD, and for the detection of new retinal tears in patients without retinal detachment. CONCLUSION: B-scan U/S scan was highly sensitive in identifying the pathology in acute FOVH. Our results show an improvement from previously reported results, likely related to the standardized scan protocol and dedicated ophthalmic ultrasonographer.

Rate of posterior capsule opacification in eyes with the Akreos intraocular lens.

PURPOSE: To determine the rate of posterior capsule opacification (PCO) in eyes with an Akreos Adapt or Akreos Fit intraocular lens (IOL) (Bausch & Lomb) over a minimum follow-up of 18 months. SETTING: Department of Ophthalmology, Worthing and Southlands Hospital NHS Trust, Worthing, United Kingdom. METHOD: This was a retrospective analysis of 102 patients who had uneventful phacoemulsification with implantation of an Akreos Adapt IOL or Akreos Fit IOL from September 2001 to May 2004. Patients from a single surgeon's operating list were recruited into the study. Exclusion criteria included posterior subcapsular cataract, history of uveitis, diabetic retinopathy, glaucoma, and age-related macular degeneration. The protocol included the determination of logMAR best corrected visual acuity (BCVA) and PCO scoring using the Evaluation of Posterior Capsular Opacification System (EPCO 2000) by digital photography of the posterior capsule. The number of patients having a neodymium:YAG (Nd:YAG) capsulotomy was also recorded. RESULTS: The mean follow-up was 30 months +/- 10.3 (SD). The mean BCVA was 20/32 (0.2 logMAR). The mean EPCO score at the central 6.0 mm of the posterior capsule was 0.39 +/- 0.53 and at the central 3.0 mm, 0.18 +/- 0.40. The Nd:YAG capsulotomy rate was 8.8%. CONCLUSIONS: All patients had stable visual acuity with low rates of PCO 2.5 years after surgery. The PCO rate with the Akreos IOL was similar to that with other acrylic IOLs reported in the literature.